fbpx

World Pharma News

16

Sep2021
The FDA’s approval of Exkivity marks the first approved oral therapy for this subgroup of patients with non-small ... Read More

16

Sep2021
BridgeBio Pharma Inc. on Wednesday said the U.S. Food and Drug Administration granted fast-track designation to BBP-418 as ... Read More

16

Sep2021
CAMBRIDGE, Mass., September 15, 2021--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq:SAGE), a biopharmaceutical company committed to developing novel therapies with ... Read More

16

Sep2021
London, UK; 15 September 2021 – Pulmocide Ltd. (“the Company”), a late-stage biopharmaceutical company focused on the development ... Read More
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X